Sudden cardiac death secondary to antidepressant and antipsychotic drugs

By Sicouri Serge   Antzelevitch Charles  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 181-194

Informa Healthcare

Access to resources Recommend Favorite

Utility of the Exercise Electrocardiogram Testing in Sudden Cardiac Death Risk Stratification

By Refaat Marwan M.   Hotait Mostafa   Tseng Zian H.  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 4, 2014-07 ,pp. : 311-318

Blackwell Publishing

Access to resources Recommend Favorite

Therapeutic developments in sudden cardiac death

By Goldberger J.J.   Neelagaru S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2543-2554

Informa Healthcare

Access to resources Recommend Favorite

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death

By Spath M.A.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 727-738

Adis International

Access to resources Recommend Favorite